Evacetrapib: all 25 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Study of Different Particle Sizes of Evacetrapib in Healthy ParticipantsCompletedNCT02497391Phase 1Results posted
• A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy ParticipantsCompletedNCT02271425Phase 1Results posted
• A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary HypercholesterolemiaTerminatedNCT02260648Phase 3Results posted
• A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary HypercholesterolemiaTerminatedNCT02260635Phase 3Results posted
• A Study of Evacetrapib (LY2484595) in Participants With High CholesterolTerminatedNCT02227784Phase 3Results posted
• A Study of Evacetrapib in Healthy Japanese ParticipantsCompletedNCT02226653Phase 1Results posted
• A Study of Evacetrapib in Participants With Abnormal CholesterolCompletedNCT02168803Phase 1Results posted
• Study of Evacetrapib (LY2484595) and Warfarin in Healthy ParticipantsCompletedNCT02161731Phase 1Results posted
• A Study of Evacetrapib With Selected Statins in Healthy Chinese ParticipantsCompletedNCT02156492Phase 1Results posted
• A Study of Evacetrapib in Japanese and Non-Japanese ParticipantsCompletedNCT01958489Phase 1Results posted
• A Study of Evacetrapib and Rifampin in Healthy ParticipantsCompletedNCT01908582Phase 1Results posted
• A Study of Evacetrapib (LY2484595) in Healthy ParticipantsCompletedNCT01903434Phase 1Results posted
• A Study of Evacetrapib and Digoxin in Healthy ParticipantsCompletedNCT01897493Phase 1Results posted
• A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) ImpairmentCompletedNCT01836185Phase 1Results posted
• A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy ParticipantsCompletedNCT01825889Phase 1Results posted
• A Study of Evacetrapib (LY2484595) and Warfarin in Healthy ParticipantsCompletedNCT01825876Phase 1Results posted
• Study of Food on Evacetrapib (LY2484595) in Healthy ParticipantsCompletedNCT01810432Phase 1Results posted
• A Study of Evacetrapib in Healthy Female ParticipantsCompletedNCT01746732Phase 1Results posted
• A Study of Evacetrapib in Healthy ParticipantsCompletedNCT01736254Phase 1Results posted
• A Study of Evacetrapib in High-Risk Vascular DiseaseTerminatedNCT01687998Phase 3Results posted
• A Study of LY2484595 on the Electrical Activity of the HeartCompletedNCT01537887Phase 1Results posted
• A Study of LY2484595 in Healthy SubjectsCompletedNCT01450098Phase 1Results posted
• A Study of LY2484595 on Pharmacokinetics in Healthy ParticipantsCompletedNCT01448824Phase 1Results posted
• A Study of LY2484595 in Japanese SubjectsCompletedNCT01375075Phase 2Results posted
• A Study of LY2484595 in Patients With High LDL-C or Low HDL-CCompletedNCT01105975Phase 2Results posted

← Evacetrapib overview